| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | SVP, Regulatory Affairs and Qa
1 company
Deepika Jalota is Chief Development Officer at PMVP. Deepika Jalota's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $124K at current prices.
Historically, Deepika Jalota's trades have earned a middling insider score of 61/100 across 4 rated trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +33.4%.
The PMVP filings lean toward selling, a net 47,283 shares.
Deepika Jalota has 12 Form 4 filings on record from May 2021 to March 2026, all as Chief Development Officer at PMV Pharmaceuticals (PMVP), 2021–2026.
The 18 reported transactions were 8 option or other derivative awards, 4 open-market sales, 3 dispositions back to the company and 2 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $171K.
The largest open-market sale was 2,896 shares of PMVP at an average $33.78 on August 17, 2021, about $98K. Twelve months later PMVP was down 56%.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | PMVP Pmv Pharmaceuticals, Inc. | Chief Development Officer | Sell | 33,065 | $1.06 | $35,197.69 | -26.9% | +38.1% | +18.1% | |
| Sep 11, 2024 | PMVP Pmv Pharmaceuticals, Inc. | Chief Development Officer | Sell | 7,218 | $1.50 | $10,852.98 | -5.8% | +6.0% | -18.5% | |
| Sep 15, 2023 | PMVP Pmv Pharmaceuticals, Inc. | Chief Development Officer | Sell | 4,104 | $6.62 | $27,168.48 | -12.1% | -66.0% | -77.5% | |
| Aug 17, 2021 | PMVP Pmv Pharmaceuticals, Inc. | SVP, Regulatory Affairs and Qa | Sale+OE | 2,896 | $33.78 | $97,814.14 | - | -30.7% | -55.6% |